NewsPanache Digilife Limited Reports No Deviation in Preferential Issue Fund Utilization for Q4FY26Panache Digilife Limited Reports No Deviation in Preferential Issue Fund Utilization for Q4FY26
Panache Digilife Limited filed its Q4FY26 compliance report confirming no deviation in utilization of Rs. 4,77,49,500 raised through preferential issue of convertible warrants dated January 5, 2026. The entire amount was utilized for business growth, general corporate purposes, and working capital requirements as originally stated. The Audit Committee review found no deviations, with the report signed by key officers on April 29, 2026.
*this image is generated using AI for illustrative purposes only.
Panache Digilife Limited has submitted its quarterly compliance report to the National Stock Exchange, confirming no deviation in the utilization of funds raised through its preferential issue of convertible warrants for the quarter ended March 31, 2026.
Fund Raising Details
The company's preferential issue was completed on January 5, 2026, with the receipt of Rs. 4,77,49,500, representing the balance 75% of the total consideration for convertible warrants. The filing was made pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirement) Regulation, 2015.
| Parameter: | Details |
|---|---|
| Mode of Fund Raising: | Preferential Issue of Convertible Warrants |
| Date of Allotment: | January 5, 2026 |
| Amount Raised: | Rs. 4,77,49,500 |
| Reporting Quarter: | March 31, 2026 |
| Deviation Status: | No Deviation/Variation |
Fund Utilization Status
The company has fully utilized the raised funds according to their original allocation. The proceeds were designated for growth in the business, general corporate purposes, and working capital requirements.
| Utilization Details: | Amount (Rs.) |
|---|---|
| Original Allocation: | 4,77,49,500 |
| Funds Utilized: | 4,77,49,500 |
| Deviation Amount: | NIL |
Compliance and Review
The statement was duly reviewed by the company's Audit Committee, which provided no comments, indicating satisfactory compliance with the stated fund utilization objectives. The report was signed by Company Secretary & Compliance Officer Harshil Chheda and CFO & Whole Time Director Nitesh Savla on April 29, 2026.
The filing confirms that there were no modifications to the original objects, no changes in allocation amounts, and no deviations in the actual utilization of funds as against the originally disclosed purposes. This compliance demonstrates the company's adherence to regulatory requirements and transparent fund management practices.
When will the convertible warrants be eligible for conversion into equity shares and at what conversion price?
What specific growth initiatives or business expansion plans will Panache Digilife pursue following this successful fund utilization?
How might the potential dilution from warrant conversion impact existing shareholders' ownership percentages?
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
